Trial
NCT01483274
Decitabine and Vaccine Therapy for Patients With Relapsed AML Following Allogeneic Stem Cell Transplantation
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Louisville
Collaborators
—
Condition
Acute Myelogenous Leukemia
Intervention
Vaccine
Why stopped
Adult patient population barriers.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-05-09